Jpmorgan Chase & Co »

Rigel Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $425k 26k 16.18
2024-06-30 $149k 18k 8.22

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
BlackRock
Morgan Stanley
Invesco
Soleus Capital Management
Vanguard Group
Susquehanna International
Assenagon Asset Management
Acadian Asset Management
Geode Capital Management
State Street Corporation
Stonepine Capital Management
CM Management
Ing Investment Management

View all funds holding Rigel Pharmaceuticals